osimertinibdurvalumabpembrolizumabalectinib
…state health sector in which several novel cancer drugs such as osimertinib, alectinib and immunotherapy are not approved for use in advanc…
1articles mentioning drugs
6drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: Neoadjuvant nivolumab ×
Neoadjuvant nivolumab
This drug is selected. Its supporting articles are shown below.